Sign in

Sarah Nash

Independent Chair of the Board at Bath & Body WorksBath & Body Works
Board

About Sarah E. Nash

Independent Chair of the Board at Bath & Body Works (BBWI); age 71; director since 2019 (tenure ~5.9 years). Previously Executive Chair (Feb 2022–Jan 2023) and Interim CEO (May–Nov 2022) during leadership transition; CEO & owner of Novagard Solutions since 2018; retired Vice Chairman of Global Investment Banking at JPMorgan after nearly 30 years (retired July 2005). BA, Vassar College; recognized for capital markets, strategic transactions, operations, and corporate governance expertise .

Past Roles

OrganizationRoleTenureCommittees/Impact
Bath & Body WorksExecutive Chair; Interim CEOExecutive Chair: Feb 2022–Jan 2023; Interim CEO: May–Nov 2022Led transition after CEO resignation; continuity of governance
Novagard SolutionsCEO & Owner2018–presentOperates industrial silicones and foam solutions manufacturer; operating leadership
JPMorgan Chase & Co.Vice Chairman, Global Investment Banking~30 years; retired July 2005Capital markets, strategic transactions leadership
Knoll, Inc.Director2006–2021 (until acquisition by Herman Miller)Design/furniture sector governance experience

External Roles

OrganizationRoleStartNotes
Blackbaud, Inc.Director (public company)2010Current public board service
HBD Industries, Inc.Directorn/aPrivate company board
New York-Presbyterian HospitalTrusteen/aNon-profit governance
Smithsonian Tropical Research Institute (Panama)Membern/aScientific institution advisory role
Montreal Museum of Fine ArtsChair, International Advisory Boardn/aCultural institution leadership
Cleveland Museum of ArtTrusteen/aCultural institution governance

Board Governance

  • Board leadership: Independent Chair (Nash); CEO and Chair roles separated; no Lead Independent Director needed due to independent Chair .
  • Independence: All directors except the CEO are independent. Board assessed Nash’s interim executive service and one-time 2022 RSU award and affirmed her independence under NYSE standards after that service ended .
  • Attendance: Board held six meetings in fiscal 2024; all then-current directors attended at least 75% of board and committee meetings; nearly all attended the 2024 annual meeting .
  • Executive sessions: Independent directors meet in executive session at every regular Board meeting; Nash chairs those sessions .
  • Committees (100% independent): Nash is not listed on standing committees; she serves as Board Chair.
    • Audit Committee: Chair Steven Voskuil; members Francis Hondal, Juan Rajlin, Stephen Steinour, J.K. Symancyk; 8 meetings; all members qualify as “audit committee financial expert” .
    • Human Capital & Compensation (HCC): Chair Francis Hondal; members Alessandro Bogliolo, Lucy Brady, Danielle Lee, Stephen Steinour, Steven Voskuil; 7 meetings; oversees compensation philosophy, clawbacks, ownership guidelines .
    • Nominating & Governance: Chair Alessandro Bogliolo; members Lucy Brady, Danielle Lee, Juan Rajlin, J.K. Symancyk; 4 meetings; oversees board refreshment and evaluations .

Fixed Compensation

  • Director cash retainer schedule (FY2024):
    • Board Chair cash retainer: $250,000 .
    • Other directors: $100,000; Audit/HCC membership: +$25,000; Nominating & Governance membership: +$20,000; Committee Chairs: Audit/HCC +$25,000; N&G +$20,000 .
  • Sarah Nash FY2024 director compensation:
    • Cash: $250,000 .
    • Committee fees: $0 (not a standing committee member) .
    • Total cash: $250,000 .
ComponentFY2024 Amount ($)
Board Chair Cash Retainer250,000
Committee Membership Fees0
Total Cash250,000

Performance Compensation

  • Director equity retainer (RSUs):
    • Board Chair annual stock retainer: $250,000; vests one year after grant, generally subject to continued service; RSUs granted under the 2020 Plan .
    • Sarah Nash FY2024 stock awards (grant-date fair value): $245,030; one-year vesting .
Equity ElementFY2024 Grant-Date Fair Value ($)Vesting Terms
Annual RSU Retainer (Board Chair)245,030 RSUs vest one year post-grant, continued service required

No director options or PSUs are disclosed for directors; equity is time-vested RSUs. Performance metrics (operating income margin, relative TSR) apply to executive PSUs, not to directors .

Other Directorships & Interlocks

AreaDetail
Current public boardsBlackbaud, Inc. (since 2010)
Former public boardsKnoll, Inc. (2006–2021)
HCC Participation & InterlocksNo HCC member is a current/former BBWI officer; no cross-compensation committee interlocks with BBWI executives on other companies’ boards

Expertise & Qualifications

  • Capital markets and corporate finance (JPMorgan vice chair; ~30 years) .
  • Strategic transactions and operations (Novagard CEO & owner) .
  • Corporate governance leadership (Independent Board Chair; prior Executive Chair/Interim CEO) .
  • Board service across public/private and non-profit institutions .

Equity Ownership

HolderShares Beneficially Owned% of ClassNotes
Sarah E. Nash259,714<1%As of April 8, 2025; no pledged shares by board members or NEOs
  • Director stock ownership guidelines: All independent directors must own BBWI common stock equal to 6x annual cash retainer by October 2028; all directors are in compliance or on track .

Insider Trades

DateTypeSharesNotes / Source
2024-06-18Sale48,000Director sale reported; article cites SEC Form 4
2025-03-12Form 4 (RSUs)n/aFiling notes 1-for-1 conversion; final tranche vesting on March 10, 2025

Company insider trading policy prohibits hedging and short-selling; pledging requires advance approval; none of the Company’s stock held by NEOs or Board members is pledged .

Governance Assessment

  • Board effectiveness: Robust governance framework with independent Chair, 90% independent directors, separated CEO/Chair roles, independent committees, regular executive sessions, and annual self-evaluations; strong shareholder rights (majority voting, proxy access, special meetings at 25%) .
  • Independence & conflicts: Board formally determined Nash remains independent post-interim executive service and one-time RSU award; no related person transactions in FY2024; HCC shows no interlocks; use of independent compensation consultants (Wills Towers Watson in 2024; Meridian in 2025) with independence checks .
  • Alignment & incentives: Director equity retainer and 6x ownership guideline support alignment; Nash held 259,714 shares as of April 8, 2025; say-on-pay support was high (96.05%) in 2024, indicating investor endorsement of compensation governance .
  • Engagement & attendance: Board met six times; all directors met the 75%+ attendance threshold; independent directors meet every regular meeting without management, chaired by Nash .
  • Risk indicators & red flags: No related-party transactions disclosed; no pledging; notable open-market sale of 48,000 shares in June 2024 is a signal to monitor for trading cadence but not, by itself, a governance breach given ownership guidelines and independence affirmations .